Melanocortin receptor research
PT-141.
Cyclic melanocortin-receptor agonist derived from α-MSH. The active molecule in Vyleesi (FDA-approved 2019, prescription-only for HSDD); research-peptide formulations are sold under research-use-only labelling and are not approved for human therapeutic use.
Long-form research guide
Reproductive Health Research. Mechanism + protocols + safety.
Melanocortin receptor pharmacology and sexual behaviour in preclinical models
Open the long-form guide for PT-141 →